Barclays PLC Grows Stock Holdings in Paragon 28, Inc. (NYSE:FNA)

Barclays PLC raised its stake in Paragon 28, Inc. (NYSE:FNA) by 180.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,812 shares of the company’s stock after buying an additional 54,591 shares during the period. Barclays PLC owned approximately 0.10% of Paragon 28 worth $567,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of FNA. Wellington Management Group LLP grew its holdings in shares of Paragon 28 by 7.0% in the 3rd quarter. Wellington Management Group LLP now owns 694,799 shares of the company’s stock worth $4,641,000 after acquiring an additional 45,215 shares during the period. State Street Corp grew its holdings in Paragon 28 by 2.6% in the third quarter. State Street Corp now owns 1,563,331 shares of the company’s stock valued at $10,443,000 after purchasing an additional 39,075 shares during the last quarter. Stonepine Capital Management LLC purchased a new position in shares of Paragon 28 in the third quarter valued at $766,000. Charles Schwab Investment Management Inc. increased its position in shares of Paragon 28 by 4.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 343,565 shares of the company’s stock valued at $2,295,000 after buying an additional 15,064 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new position in shares of Paragon 28 during the 3rd quarter worth $70,000. 63.57% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, major shareholder Mvm Partners, Llc sold 4,256 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $10.00, for a total transaction of $42,560.00. Following the transaction, the insider now directly owns 10,499,960 shares in the company, valued at $104,999,600. This represents a 0.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders sold a total of 252,914 shares of company stock valued at $2,585,514 over the last quarter. Company insiders own 15.32% of the company’s stock.

Paragon 28 Price Performance

NYSE:FNA opened at $10.33 on Thursday. The firm has a market cap of $864.83 million, a price-to-earnings ratio of -13.96 and a beta of 1.52. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The company’s 50-day moving average is $9.03 and its two-hundred day moving average is $7.75.

Paragon 28 (NYSE:FNA) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.01. The business had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The company’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.10) earnings per share. Research analysts expect that Paragon 28, Inc. will post -0.66 EPS for the current year.

Analyst Upgrades and Downgrades

FNA has been the topic of a number of research reports. Needham & Company LLC increased their price objective on shares of Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Canaccord Genuity Group lowered their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Stephens upgraded Paragon 28 to a “strong-buy” rating in a research report on Monday, December 2nd. Four analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $15.60.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.